Pharmaceutical Science to Improve the Human Condition
Prix Galien 2010, Volume 1222
Seiten
2011
Wiley-Blackwell (Verlag)
978-1-57331-835-8 (ISBN)
Wiley-Blackwell (Verlag)
978-1-57331-835-8 (ISBN)
- Titel z.Zt. nicht lieferbar
- Versandkostenfrei
- Auch auf Rechnung
- Artikel merken
This Annals volume includes scholarly summaries of scientific achievement by winners and finalists candidates of the 2010 Prix Galien USA, Prix Galien International, and Prix Galien Bro Bono Humanitarian Awards ( http://www. prix-galien-usa. com/index.
This Annals volume includes scholarly summaries of scientific achievement by winners and finalists candidates of the 2010 Prix Galien USA, Prix Galien International, and Prix Galien Bro Bono Humanitarian Awards (http://www.prix-galien-usa.com/index.php). The Prix Galien was created in France by pharmacist Roland Mehl, whose aim was to promote the country's significant advances in pharmaceutical research. Until the establishment of the Prix Galien, this discipline was unrecognized. Mehl brought together an eminent jury of clinicians, toxicologists, pharmacologists, and pharmacists to select and honor the most important drugs introduced to the public market and the most significant research teams in the pharmaceutical field. Since then, the Prix Galien has been introduced across Europe and Canada, and is now the most prestigious award of its kind in 11 countries. In addition, an International Prix Galien award is given each year, selected from previous winners. Contributions in the present volume — from top researchers in the biopharmaceutical industry, and the esteemed Bro Bono Humanitarian award winners President William Clinton and Dr. Philippe Douste-Blasy, with a special introduction by Secretary-General of the United Nations Ban Ki-moon — best embody humanitarianism and therapeutic promise in global healthcare problems. Winners and select finalists of the 2010 Prix Galien prizes represent biotechnical advances poised to combat a wide range of diseases and viruses.
NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please click here.
ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.
This Annals volume includes scholarly summaries of scientific achievement by winners and finalists candidates of the 2010 Prix Galien USA, Prix Galien International, and Prix Galien Bro Bono Humanitarian Awards (http://www.prix-galien-usa.com/index.php). The Prix Galien was created in France by pharmacist Roland Mehl, whose aim was to promote the country's significant advances in pharmaceutical research. Until the establishment of the Prix Galien, this discipline was unrecognized. Mehl brought together an eminent jury of clinicians, toxicologists, pharmacologists, and pharmacists to select and honor the most important drugs introduced to the public market and the most significant research teams in the pharmaceutical field. Since then, the Prix Galien has been introduced across Europe and Canada, and is now the most prestigious award of its kind in 11 countries. In addition, an International Prix Galien award is given each year, selected from previous winners. Contributions in the present volume — from top researchers in the biopharmaceutical industry, and the esteemed Bro Bono Humanitarian award winners President William Clinton and Dr. Philippe Douste-Blasy, with a special introduction by Secretary-General of the United Nations Ban Ki-moon — best embody humanitarianism and therapeutic promise in global healthcare problems. Winners and select finalists of the 2010 Prix Galien prizes represent biotechnical advances poised to combat a wide range of diseases and viruses.
NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please click here.
ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.
For 200 yearssince 1817the Academy has brought together extraordinary people working at the frontiers of discovery. Among the oldest scientific organizations in the United States, it has become not only an enduring cultural institution in New York, but also one of the most significant organizations in the global scientific community.
| Erscheint lt. Verlag | 10.6.2011 |
|---|---|
| Reihe/Serie | Annals of the New York Academy of Sciences |
| Verlagsort | Hoboken |
| Sprache | englisch |
| Maße | 180 x 257 mm |
| Gewicht | 245 g |
| Themenwelt | Medizin / Pharmazie ► Pflege |
| Medizin / Pharmazie ► Pharmazie ► PTA / PKA | |
| Naturwissenschaften ► Biologie | |
| ISBN-10 | 1-57331-835-3 / 1573318353 |
| ISBN-13 | 978-1-57331-835-8 / 9781573318358 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
